SEC Form 4 · accession 0001179110-15-006447
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard P Shea
Officer — SVP, CFO
Period of report
Mar 29, 2015
Accepted (ET)
Apr 20, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 29, 2015 | D | 6,750 | $0.00 | D | 151,041 | D | |
| Common StockF2 | Apr 16, 2015 | F | 6,215 | $17.08 | D | 144,826 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between Mr. Shea and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- F2Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Shea and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.